PharmAla Files Amended and Restated Preliminary Base Shelf Prospectus
TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”…
IOC Executive Board approves Olympic medal reallocations for Vancouver 2010 and Sochi 2014
19 September 2025 - The International Olympic Committee (IOC) Executive Board (EB) today took the…
IOC Executive Board approves 13 athletes changes of sporting nationality for the Milano Cortina 2026 Olympic Winter Games
19 September 2025 - Today, during the second day of its meeting…
IOC reaffirms: Sport must unite the world in peaceful competition
19 September 2025 - In a world shaken by conflict and division, the…
Bravo Flowdex: How This Innovative Platform is Redefining AI Trading Read Bravo Flowdex Spain Report!
New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction –…
Net Rowdex: Why Net Rowdex 2025 Emerges as a Next-Gen AI Trading Platform for Investors Read France Report!
New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction to…
Immediate Edge: Exploring the AI Technology Behind Immediate Edge Trading Platform Germany Insights!
New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction to…
Sasken Partners with VicOne to Deliver End-to-End Automotive Cybersecurity Solutions
BENGALURU, India, Sept. 20, 2025 /PRNewswire/ -- Sasken Technologies Limited, a leader…
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in…
Multiple Myeloma Research Foundation (MMRF) Announces New Data from Flagship Research Initiatives at the 22nd International Myeloma Society Annual Meeting
NORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the Multiple Myeloma…
